Insights from DOCK2 in cell function and pathophysiology
L Ji, S Xu, H Luo, F Zeng - Frontiers in molecular biosciences, 2022 - frontiersin.org
Dedicator of cytokinesis 2 (DOCK2) can activate the downstream small G protein Rac and
regulate cytoskeletal reorganization. DOCK2 is essential for critical physiological processes …
regulate cytoskeletal reorganization. DOCK2 is essential for critical physiological processes …
Update on novel targeted therapy for pleural organization and fibrosis
Pleural injury and subsequent loculation is characterized by acute injury, sustained
inflammation and, when severe, pathologic tissue reorganization. While fibrin deposition is a …
inflammation and, when severe, pathologic tissue reorganization. While fibrin deposition is a …
[HTML][HTML] Characterization of the pleural microenvironment niche and cancer transition using single-cell RNA sequencing in EGFR-mutated lung cancer
Background: Lung cancer is associated with a high mortality rate and often complicated with
malignant pleural effusion (MPE), which has a very poor clinical outcome with a short life …
malignant pleural effusion (MPE), which has a very poor clinical outcome with a short life …
The mTORC2/SGK1/NDRG1 Signaling Axis Is Critical for the Mesomesenchymal Transition of Pleural Mesothelial Cells and the Progression of Pleural Fibrosis
S Keshava, S Owens, W Qin, A Jeffers… - American Journal of …, 2024 - atsjournals.org
Progressive lung scarring because of persistent pleural organization often results in pleural
fibrosis (PF). This process affects patients with complicated parapneumonic pleural …
fibrosis (PF). This process affects patients with complicated parapneumonic pleural …
Role of ZIP kinase in development of myofibroblast differentiation from HPMCs
YY Choo, T Sakai, R Ikebe, A Jeffers… - … of Physiology-Lung …, 2024 - journals.physiology.org
During the development of pleural fibrosis, pleural mesothelial cells (PMCs) undergo
phenotypic switching from differentiated mesothelial cells to mesenchymal cells (MesoMT) …
phenotypic switching from differentiated mesothelial cells to mesenchymal cells (MesoMT) …
DOCK2 contributes to pulmonary fibrosis by promoting lung fibroblast to myofibroblast transition
X Guo, O Adeyanju, C Sunil… - … of Physiology-Cell …, 2022 - journals.physiology.org
Idiopathic pulmonary fibrosis (IPF) is the most common chronic interstitial lung disease and
is characterized by progressive scarring of the lung. Transforming growth factor-β (TGF-β) …
is characterized by progressive scarring of the lung. Transforming growth factor-β (TGF-β) …
Silencing DOCK2 Attenuates Cardiac Fibrosis Following Myocardial Infarction in Mice Via Targeting PI3K/Akt and Wnt/β-Catenin Pathways
G Hu, J Chen, M Chen, K Yang, Y Wang, Z Ma… - Journal of …, 2024 - Springer
Cardiac fibrosis following myocardial infarction (MI) seriously affects the prognosis and
survival rate of patients. This study aimed to determine the effect and regulation mechanism …
survival rate of patients. This study aimed to determine the effect and regulation mechanism …
[HTML][HTML] Dedicator of cytokinesis protein 2 activates the epithelial–mesenchymal transition in renal fibrosis through the Rac1/PI3K/AKT pathway
Y Jia, J Sun, S Chen, Y Bian, A Jiang, H Liang… - Biochimica et Biophysica …, 2024 - Elsevier
Renal fibrosis is the most important feature of the progression of chronic kidney disease
(CKD), and epithelial–mesenchymal transition (EMT) plays an important role in renal …
(CKD), and epithelial–mesenchymal transition (EMT) plays an important role in renal …
DOCK2 Promotes Asthma Development by Eliciting Airway Epithelial–Mesenchymal Transition
Epithelial–mesenchymal transition (EMT) contributes to airway remodeling, a predominant
feature of asthma. DOCK2 (dedicator of cytokinesis 2) is an innate immune signaling …
feature of asthma. DOCK2 (dedicator of cytokinesis 2) is an innate immune signaling …
DOCK2 Promotes Atherosclerosis by Mediating the Endothelial Cell Inflammatory Response
The pathology of atherosclerosis, a leading cause of mortality in patients with cardiovascular
disease, involves inflammatory phenotypic changes in vascular endothelial cells. This study …
disease, involves inflammatory phenotypic changes in vascular endothelial cells. This study …